Quarterly Results • Search Archive
Eris Lifesciences Limited
Results, Financials & Updates
Follow Eris Lifesciences Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Eris Lifesciences Limited: latest results and financials
About the business in Nivata's latest coverage
Eris Lifesciences Limited is a specialty pharmaceutical company focused on the domestic branded formulations (DBF) market in India, with a strong emphasis on chronic and sub-chronic therapeutic segments. The company's core product portfolio spans major medical specialties including oral anti-diabetics (OAD), insulin, cardiovascular care, dermatology, vitamins, minerals, and nutrients (VMN), oncology, nephrology, and neurology.
Quarter history
Eris Lifesciences Limited Results & Financials
Latest Nivata coverage: Q1 FY27 · revenue ₹873.25 Cr · PAT ₹143.32 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.